Market Cap 15.14M
Revenue (ttm) 13.80M
Net Income (ttm) -13.58M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -98.41%
Debt to Equity Ratio 0.00
Volume 49,712
Avg Vol 143,764
Day's Range N/A - N/A
Shares Out 5.89M
Stochastic %K 13%
Beta 7.31
Analysts Sell
Price Target $6.30

Latest News on VVOS

Vivos Therapeutics, Inc. (VVOS) Q3 2024 Earnings Call Transcript

Nov 14, 2024, 11:31 PM EST - 5 months ago

Vivos Therapeutics, Inc. (VVOS) Q3 2024 Earnings Call Transcript


Vivos Therapeutics, Inc. (VVOS) Q2 2024 Earnings Call Transcript

Aug 15, 2024, 2:05 PM EDT - 8 months ago

Vivos Therapeutics, Inc. (VVOS) Q2 2024 Earnings Call Transcript


Vivos Therapeutics, Inc. (VVOS) Q1 2024 Earnings Call Transcript

May 17, 2024, 9:02 PM EDT - 11 months ago

Vivos Therapeutics, Inc. (VVOS) Q1 2024 Earnings Call Transcript


Vivos Therapeutics Closes $4 Million Private Placement

Nov 2, 2023, 5:00 PM EDT - 1 year ago

Vivos Therapeutics Closes $4 Million Private Placement


Vivos Therapeutics Announces Reverse Stock Split

Oct 26, 2023, 7:30 AM EDT - 1 year ago

Vivos Therapeutics Announces Reverse Stock Split